SPONSOR
Institute of Mental Health, Singapore
Total Trials
2
Recruiting
2
Phases
Phase 3
Institute of Mental Health, Singapore is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Schizophrenia; Negative Type, Subthreshold Depression.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institute of Mental Health, Singapore
How many clinical trials has Institute of Mental Health, Singapore sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Institute of Mental Health, Singapore, of which 2 are actively recruiting participants. These trials cover conditions including Schizophrenia; Negative Type, Subthreshold Depression. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institute of Mental Health, Singapore research focus on?
Institute of Mental Health, Singapore clinical trials span Schizophrenia; Negative Type, Subthreshold Depression. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institute of Mental Health, Singapore clinical trial?
To participate in a Institute of Mental Health, Singapore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institute of Mental Health, Singapore trials with current recruitment status updated daily.
Clinical Trials by Institute of Mental Health, Singapore
NCT06351514 Phase 3
Recruiting
An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms
Schizophrenia; Negative Type
NCT07118072
Recruiting
A Pilot Study to Examine the Efficacy of Internet-Delivered Skills Training in Affective and Interpersonal Regulation (i-STAIR) for Individuals With Adverse Childhood Experiences and Subsyndromal Depression
Subthreshold Depression
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology